Taiwan FDA registration f8b52aeef7734e4785d4a57494be4dab
"Siemens" Alpha-1-antitrypsin reagent group
TW: “西門子”Alpha-1-抗胰蛋白試劑組
Taiwan·Risk Class 2·RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Jan 24, 2008 – Jan 24, 2028ActiveRegistration details
- Analysis ID
- f8b52aeef7734e4785d4a57494be4dab
- Customs Code
- DHA00601894104
Company information
- Manufacturer Country
- United Kingdom;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- Quantitatively determine alpha-1-antitrypsin in human serum and plasma on the ADVIA Automated Chemical Analysis System.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5130 α-1-抗胰蛋白免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Jan 24, 2008
- Expiry Date
- Jan 24, 2028
About this record
Access comprehensive regulatory information for "Siemens" Alpha-1-antitrypsin reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f8b52aeef7734e4785d4a57494be4dab and manufactured by RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices